The poultry vaccines market size is projected to reach US$ 4.1 billion by 2031 from US$ 2.1 billion in 2023. The market is expected to register a CAGR of 8.6% in 2023–2031. The advancements in vectored and combination vaccines are likely to remain key poultry vaccines market trends.

Poultry Vaccines Market Analysis

Rising Prevalence of Poultry Diseases

Poultry production results in producing different types of animal proteins through eggs and meat. With rising poultry production, there are high chances of susceptibility to several zoonotic diseases such as “Fowl disease” that might result in huge economic losses, particularly in developing countries. For example, chickens are more prone to bacterial, viral, parasitic, and fungal infections. These viral outbreaks can cause Newcastle disease, avian influenza, infectious bursal disease, and other diseases to a wide range of poultry animals.

The table below provides disease outbreaks of avian influenza among mammals across several countries in 2022.

Cases of Avian Influenza in Mammals
Country	Poultry Diseases	Disease Outbreak (2022)
Argentina	H5	18
Chile		34
Norway		2
Uruguay		3
Peru		12
Brazil	H5N1	5
Canada		40
China		1
Estonia		1
Finland		76
France		2
Ireland		2
Italy		3
Japan		4
Russia		1
Canada	H5N5	2
Denmark	H5N8	1

Source: World Organization for Animal Health 2023

Poultry diseases are a major cause of death of chicks and also lead to reduced livestock. Farmers are facing huge economic losses worldwide as they spread zoonotic diseases, posing a serious health risk to mammals. For example, poultry coccidiosis is one of the most common diseases across the globe; it leads to huge losses associated with mortality, reduced body weight, and extra expenses related to preventive and therapeutic control. As per the DSM company website, farmers face an economic loss of US$ 3 billion annually owing to coccidiosis in chickens and avian species worldwide. Newcastle disease is also considered an economically expensive disease causing huge production losses to the farmers of developing countries that export poultry products. The International Journal of Current Microbiology and Applied Sciences (IJCMAS) report published in October 2021 reveals that total losses due to Newcastle disease mortality and total expenditure on live birds in all the 25 commercial broiler farms ranged between INR 17,864 (US$ 214.0) to INR 2,66,080 (US$ 3,188.89) and INR 2,78,393 (US$ 3,336.46) to INR 17,86,745 (US$ 21,413.6), respectively. Also, the selling income of live birds from individual farms ranged from INR 1,60,255 (US$ 1,920.61) to INR 12,46,314 (US$ 14,936.7) due to infection.

Therefore, the rising prevalence of poultry diseases resulting in huge economic losses boosts the demand for poultry vaccinations, which drives the market.

Poultry Vaccines Market Overview

India accounts for the second largest market share in Asia Pacific. India holds a considerable position in the global poultry vaccines market. The economic importance of the poultry industry can be estimated on the basis of the fact that the Indian poultry industry forms ~0.7% of the national GDP and 10% of the livestock GDP. In the recent past, the Indian poultry sector has faced a frequent onslaught of newer poultry diseases, such as bird flu (Avian Influenza or AI), leading to enormous losses to the poultry sector in India and globally. Avian influenza has emerged as an unpredictable threat to the country's poultry industry, causing more than 176 outbreaks in the last ten years, impacting substantial economic loss to the poultry industry. Every reported case of an outbreak of AI leads to distortions in domestic demand and, consequently, in prices and global trade. Scientific interventions are urgently needed to curb the menace of such emerging poultry diseases in the country. However, current practice does not incorporate avian influenza vaccine into routine vaccination programs. Thus, there is a need for a predictive analytics approach to forecast the outbreak and, more importantly, to have a safe and productive vaccine for avian influenza.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Poultry Vaccines Market: Strategic Insights

Poultry Vaccines Market

• 
  CAGR (2023 - 2031)

  8.6%
• Market Size 2023
  US$ 2.1 Billion
• Market Size 2031
  US$ 4.1 Billion

Market Dynamics

GROWTH DRIVERS

• Rising Prevalence of Poultry Diseases

FUTURE TRENDS

• Advancements in vectored and combination vaccines

OPPORTUNITIES

• Government Support for Mass Vaccination Drives and Innovative Schemes

Key Players

• Boehringer Ingelheim International GmbH,
• Zoetis Inc,
• BIOVAC,
• Phibro Animal Health,
• Hester Biosciences Ltd.,
• Venky's (India) Ltd.,
• Dechra Pharmaceuticals PLC,
• Elanco Animal Health Inc,
• Merck KgaA,
• Ceva,

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Type

• Broiler
• Layer

MateTechnology

• Live Attenuated Vaccines
• Inactivated Vaccines
• Recombinant Vaccines

Dosage Form

• Liquid Vaccines
• Freeze-Dried Vaccines
• Dust/Powder Form Vaccines

Disease

• Avian Influenza
• Avian Salmonellosis
• Marek's Disease
• Infectious Bronchitis
• Infectious Bursal Disease

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Poultry Vaccines Market Drivers and Opportunities

Advancements in Vectored and Combination Vaccines

Vectored vaccines work differently from conventional vaccines and offer several advantages. These advantages include no adverse effects/reactions, overcoming maternal antibody interference, and meeting evolving disease challenges, among others. The "Vaxxitek HVT+IBD+ND" is an example of a vector vaccine manufactured by Boehringer Ingelheim and was launched in the US market in 2019. It is a trivalent vaccine and is effective against three diseases: Marek's Disease (MD), Infectious Bursal Disease (IBD), and Newcastle disease (ND). Additionally, in 2020, a second trivalent form, "Vaxxitek HVT+IBD+ILT," received marketing authorization in the US to protect against MD, IBD, and Infectious Laryngotracheitis (ILT). These are all highly infectious and commercially disruptive diseases that affect the poultry industry worldwide, and Vaxxitek proves beneficial in overcoming such diseases in one shot. Other manufacturers except Boehringer Ingelheim producing such bivalent and trivalent vaccines will enhance global demand. Also, major manufacturers plan to procure pentavalent vaccines that will prove beneficial to overcome poultry diseases and help them stand out in the global market. Thus, the advancements in vectored and combination vaccines production acts as a new trend that is likely to boost the poultry vaccines market growth in the coming years.

Government Support for Mass Vaccination Drives and Innovative Schemes

Government worldwide is supportive against poultry vaccination with rising Global Burden of Disease (GBD). The support involves launching of mass vaccination schemes and several vaccination programs at vaccination centers or through door-step immunization services.

• In December 2022, the Indian Government announced launching of schemes such as the "Livestock Health & Disease Control Scheme" improve the animal health sector by implementing prophylactic vaccination programs against several diseases. This scheme is Central or State-driven and funded with a sharing pattern of 60:40. Also, the scheme covers "research & innovation, publicity & awareness, training & allied activities" that are 100% Center-funded.
• In April 2023, the government of France announced passing a tender for ordering 80 million doses of avian influenza vaccines as the country was preparing for a mass vaccination program. The "ANES" Ministry in France was the first country in the European Union (EU) to start such a mass vaccination scheme. For conducting such a mass vaccination drive, France mandated 2 companies, France's Ceva Animal Health and Germany's Boehringer Ingelheim, to develop avian influenza vaccines. Both vaccines by the two companies effectively protect birds against the virus.

Therefore, such government support for mass vaccination drives and designing innovative schemes is anticipated to provide lucrative opportunities for the poultry market growth in the coming years.

Poultry Vaccines Market Report Segmentation Analysis

Key segments that contributed to the derivation of the poultry vaccines market analysis are type, technology, dosage form, disease, route of administration, and end user.

• Based on type, the poultry vaccines market is divided into broiler and layer. The broiler segment held a larger market share in 2023.
• By technology, the market is segmented into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest share of the market in 2023.
• In terms of dosage form, the market is categorized into liquid vaccines, freeze-dried vaccines, and dust/powder form vaccines. The liquid vaccines segment dominated the market in 2023.
• In terms of disease, the market is segmented into avian influenza, avian salmonellosis, Marek's disease, infectious bronchitis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment dominated the market in 2023.
• In terms of route of administration, the market is categorized into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment dominated the market in 2023.
• In terms of end user, the market is segmented into poultry farms, veterinary hospitals, and poultry vaccination centers & clinics. The poultry farms segment dominated the market in 2023.

Poultry Vaccines Market Share Analysis by Geography

The geographic scope of the poultry vaccines market report is mainly segmented into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

Asia Pacific has dominated the poultry vaccines market and is anticipated to grow with the highest CAGR in the coming years. In Asia Pacific, China accounted for the largest share of the poultry vaccines market in 2022. China is witnessing rapid economic growth and urbanization. China has one of the major healthcare systems in the region. The market growth in the country can be accredited to the growing demand for poultry meat, the increasing consumption of animal-derived food products, the growing livestock population, increasing awareness about animal health, and the rising frequency of poultry disease outbreaks in China. Therefore, favorable government initiatives to promote vaccination among the population of China are the key factor influencing the poultry vaccines market growth.

Poultry Vaccines Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Poultry Vaccines Market News and Recent Developments

The poultry vaccines market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for  poultry vaccines and strategies:

• In April 2021, Boehringer Ingelheim, a global leader in animal health, announced the launch of Prevexxion RN and Prevexxion RN+HVT+IBD, the next generation of Marek’s disease vaccines, in the European Union countries and the UK. (Source: Boehringer Ingelheim, Press Release, 2021)

Poultry Vaccines Market Report Coverage and Deliverables

The “Poultry Vaccines Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles